Van Andel Institute

Stephen Tuuk is running the London Marathon for VAI October 2, 2022.
All donations will be going to VAI Linked Clinical Trials partnership with Cure Parkinson's Trust

The International Linked Clinical Trials Programme (iLCT)

Our International Linked Clinical Trials (iLCT) programme is a drug-repurposing initiative, focused on disease-modification in Parkinson’s, that operates year round. It brings together leading world experts in Parkinson’s to determine further underlying pathologies of Parkinson’s, and to discuss and debate the virtues of 20 or more promising drugs to decide which should be prioritised and managed into clinical trials.

The iLCT initiative already has momentum. There are now over 40 drugs prioritised, with many already in, or about to go in to, clinical trial. Our goal for the next five years is to ensure we can commit more potential treatments to trial for people living with Parkinson’s.